Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives. The Company is currently advancing a diverse range of anti-infectives, including a vaccine candidate to eliminate a serious biological weapon threat, a topical antiparasitic for the treatment of a disfiguring disease, and a novel easy to use, liquid oral formulation targeting parasitic and anaerobic infections. 

Biotechnology

Health Care

Therapeutics

Appili Therapeutics

Don Cilla

Leona Saunders

Art Baran

Carl Gelhaus

Gary Nabors

Kenneth Howling

The Appili Therapeutics leadership team has experience in the military, academia, and the private sector. They have worked at the United States Military Academy at West Point, the Office of Regulated Activities (ORA) at US Army Medical Materiel Development Activity (USAMMDA), University of Maryland, and the Division of Regulated Activities and Compliance (DRAC) at USAMMDA. This experience gives them a unique perspective on the needs of their customers and how to best serve them.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Appili Therapeutics

Board of Directors

CEO and Executive Team